Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases
Open Access
- 1 March 2012
- journal article
- research article
- Published by Springer Nature in Familial Cancer
- Vol. 11 (3) , 351-354
Abstract
It is estimated that about 5–10% of ovarian and 2–5% of all breast cancer patients are carriers of a germline BRCA1 or BRCA2 gene mutation. Most families with detected BRCA1 or BRCA2 gene mutation are qualified for molecular testing on the basis of family history of breast or ovarian cancers. The purpose of our study was to establish the frequency of positive family history of cancer in a series of Polish consecutive breast and ovarian cancer patients in two groups, with and without the BRCA1 gene mutations. We analysed the prevalence of four of the most common BRCA1 mutations: 5382insC (c.5266dupC), 300T>G (p.181T>G), 185delAG (c.68_69delAG) and 3819del5 (c.3700_3704del5). The patient group consisted of 1,845 consecutive female breast and 363 ovarian cancer cases. 19 out of 37 (51%) of BRCA1-positive ovarian cancer patients and 21 out of 55 (39%) BRCA1-positive breast cancer had negative family history of breast and/or ovarian cancer among first- and second-degree relatives. In ovarian cancer patients, negative family history was more frequent in those with 300T>G BRCA1 gene mutation than in 5382insC carriers. This finding indicates the necessity of searching for 300T>G mutation in families with a single diagnosis of ovarian cancer in family. The high frequency of mutations detected in breast cancer patients lacking obvious family history shows that breast cancer patients should be qualified for genetic testing on the basis of wide clinical and pathological criteria.Keywords
This publication has 23 references indexed in Scilit:
- BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implicationsCurrent Opinion in Obstetrics and Gynecology, 2010
- Prediction ofBRCAMutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United StatesJournal of Clinical Oncology, 2009
- Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast CancerJournal of Clinical Oncology, 2008
- High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in PolandGynecologic Oncology, 2008
- BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.Oncology Reports, 2008
- Prevalence of Pathogenic BRCA1 Mutation Carriers in 5 US Racial/Ethnic GroupsJAMA, 2007
- Limited Family Structure and BRCA Gene Mutation Status in Single Cases of Breast CancerJAMA, 2007
- Founder Mutations in the BRCA1 Gene in Polish Families with Breast-Ovarian CancerThe American Journal of Human Genetics, 2000
- Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern PolandHuman Mutation, 2000
- Prevalence of BRCA1 founder mutations in western PolandHuman Mutation, 2000